As per corporate shareholdings filed for Apr-2025, people matching Kynam Capital Management, LP publicly holds 35 stocks with a net worth of over US$ 1.4 B.
These are shares held by Kynam Capital Management, LP as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.
| Stock Name | Holders Name | Current Price US$ | Quantity Held | Holding Percent | Change from Previous Qtr | Holding Value US$ | History | |
|---|---|---|---|---|---|---|---|---|
| Crescent Biopharma Inc. | Kynam Capital Management, Lp | 16.84 | 89,886 | 0.24% | 0.00 | 1.5 M | ||
| Neoleukin Therapeutics Inc | Kynam Capital Management, Lp | 17.22 | 24,037 | 0.26% | 0.00 | 413.9 K | ||
| Amarin Corp - ADR | Kynam Capital Management, Lp | 16.60 | 12,414,628 | 3.00% | 0.00 | 206.1 M | ||
| Acelyrin Inc | Kynam Capital Management, Lp | 2.27 | 847,366 | 0.84% | 0.00 | 1.9 M | ||
| 2seventy bio Inc | Kynam Capital Management, Lp | 5.00 | 5,953,825 | 11.19% | 0.00 | 29.8 M | ||
| Biocryst Pharmaceuticals Inc. | Kynam Capital Management, Lp | 9.91 | 8,928,523 | 4.27% | -0.07 | 88.5 M | ||
| Beam Therapeutics Inc | Kynam Capital Management, Lp | 17.24 | 2,518,170 | 2.50% | 0.76 | 43.4 M | ||
| Burning Rock Biotech Ltd - ADR | Kynam Capital Management, Lp | 3.41 | 994,883 | 9.24% | 0.00 | 3.4 M | ||
| Cullinan Oncology Inc | Kynam Capital Management, Lp | 7.94 | 2,338,629 | 3.96% | 1.84 | 18.6 M | ||
| Cg Oncology Inc. | Kynam Capital Management, Lp | 25.94 | 2,611,662 | 3.43% | 0.12 | 67.7 M | ||
| Celldex Therapeutics Inc. | Kynam Capital Management, Lp | 21.65 | 6,500,000 | 9.79% | 2.16 | 140.7 M | ||
| Climb Bio Inc. | Kynam Capital Management, Lp | 1.20 | 1,047,000 | 1.55% | 0.74 | 1.3 M | ||
| Cogent Biosciences Inc | Kynam Capital Management, Lp | 7.32 | 9,105,000 | 8.00% | 0.00 | 66.6 M | ||
| Caribou Biosciences Inc | Kynam Capital Management, Lp | 1.42 | 3,269,147 | 3.52% | 0.93 | 4.6 M | ||
| Design Therapeutics Inc | Kynam Capital Management, Lp | 4.00 | 904,017 | 1.59% | NEW | 3.6 M | ||
| Dynavax Technologies Corp. | Kynam Capital Management, Lp | 9.96 | 2,620,797 | 2.14% | -3.22 | 26.1 M | ||
| enGene Holdings Inc | Kynam Capital Management, Lp | 3.01 | 4,994,090 | 9.78% | 0.00 | 15.0 M | ||
| Geron Corp. | Kynam Capital Management, Lp | 1.55 | 3,659,526 | 0.57% | NEW | 5.7 M | ||
| Immunocore Holdings plc - ADR | Kynam Capital Management, Lp | 31.70 | 1,695,576 | 3.38% | 0.94 | 53.7 M | ||
| Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A | Kynam Capital Management, Lp | 0.71 | 5,822,938 | 3.60% | 0.70 | 4.1 M | ||
| Legend Biotech Corp - ADR | Kynam Capital Management, Lp | 34.71 | 610,000 | 0.33% | NEW | 21.2 M | ||
| Liquidia Corp | Kynam Capital Management, Lp | 13.54 | 633,802 | 0.74% | -1.91 | 8.6 M | ||
| Nurix Therapeutics Inc | Kynam Capital Management, Lp | 12.03 | 800,000 | 1.05% | NEW | 9.6 M | ||
| Natera Inc | Kynam Capital Management, Lp | 171.52 | 1,167,570 | 0.86% | -0.63 | 200.3 M | ||
| Vaxcyte Inc | Kynam Capital Management, Lp | 34.02 | 3,200,000 | 2.48% | 0.67 | 108.9 M | ||
| ProQR Therapeutics N.V | Kynam Capital Management, Lp | 2.02 | 1,750,000 | 1.66% | 0.00 | 3.5 M | ||
| Relay Therapeutics Inc | Kynam Capital Management, Lp | 3.34 | 3,063,292 | 1.79% | 1.20 | 10.2 M | ||
| Syndax Pharmaceuticals Inc | Kynam Capital Management, Lp | 9.28 | 8,520,000 | 9.90% | 0.00 | 79.1 M | ||
| Sutro Biopharma Inc | Kynam Capital Management, Lp | 0.82 | 5,441,447 | 6.44% | 2.13 | 4.5 M | ||
| Travere Therapeutics Inc | Kynam Capital Management, Lp | 15.13 | 1,802,750 | 2.03% | 0.00 | 27.3 M | ||
| Tyra Biosciences Inc | Kynam Capital Management, Lp | 9.89 | 2,406,067 | 4.52% | 3.53 | 23.8 M | ||
| UroGen Pharma Ltd | Kynam Capital Management, Lp | 13.57 | 25,000 | 0.05% | NEW | 339.3 K | ||
| Vera Therapeutics Inc - Ordinary Shares - Class A | Kynam Capital Management, Lp | 22.62 | 2,400,000 | 3.76% | 1.48 | 54.3 M | ||
| Viridian Therapeutics Inc | Kynam Capital Management, Lp | 14.83 | 4,700,000 | 5.76% | 1.68 | 69.7 M | ||
| Wave Life Sciences Ltd. | Kynam Capital Management, Lp | 6.85 | 4,899,497 | 3.18% | 0.00 | 33.6 M | ||
| Protagonist Therapeutics Inc | 53.88 | - | Investor holds below 1% |